The Department of Veterans Affairs intends to award a single, unrestricted contract for Mesalamine 1200MG tablets, supplied in 120-count bottles with specific packaging and labeling requirements. The contract covers a one-year base period plus four one-year options, serving the VA, DoD, and other federal agencies. Distribution will occur through the Pharmaceutical Prime Vendor Programs. The solicitation is expected to be issued electronically on or about May 25, 2026, with a tentative closing date of June 9, 2026. No budget amount is specified, and the performance location is not detailed beyond federal distribution channels.